Pediatric pulmonary veno-occlusive disease associated with a novel BMPR2 variant

Pediatr Pulmonol. 2022 May;57(5):1366-1369. doi: 10.1002/ppul.25877. Epub 2022 Mar 17.

Abstract

Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) cause progressive PH on the distinct genetic impact. A 29-month-old boy presented with a loss of consciousness. He had severe PH refractory to pulmonary vasodilators. Hypoxemia and ground-glass opacity on the chest computed tomography were present, and significant pulmonary edema developed after the introduction of continuous intravenous prostaglandin I2 . Based on the clinical diagnosis of PVOD, he underwent a single living-donor lobar lung transplantation with the right lower lobe of his mother. The pathological findings of his explanted lung showed intimal thickening and luminal narrowing of the pulmonary vein. A genetic test revealed a novel heterozygous splice acceptor variant (c.77-2A>C) in BMPR2, which is typically associated with I/HPAH. This is the first pediatric case of PVOD with BMPR2 variant, supporting the concept that I/HPAH and PVOD are part of a spectrum of pulmonary vascular disease.

Keywords: bone morphogenetic protein receptor type II; pulmonary arterial hypertension; pulmonary veno-occlusive disease; single living-donor lobar lung transplantation.

Publication types

  • Letter

MeSH terms

  • Bone Morphogenetic Protein Receptors, Type II / genetics
  • Child
  • Child, Preschool
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Hypertension, Pulmonary* / diagnosis
  • Lung
  • Lung Transplantation* / adverse effects
  • Male
  • Pulmonary Veno-Occlusive Disease* / complications
  • Pulmonary Veno-Occlusive Disease* / diagnostic imaging
  • Pulmonary Veno-Occlusive Disease* / genetics

Substances

  • BMPR2 protein, human
  • Bone Morphogenetic Protein Receptors, Type II